| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 18, 2025 | Sale | $18.24 | 1,683 | 30,695 | 23,948 | Aug 20, 2025, 04:11 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 14, 2025 | Option/RSU Exercise | - | 6,000 | - | 25,631 | Aug 18, 2025, 08:24 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 13, 2025 | Sale | $15.00 | 13,712 | 205,680 | 19,631 | Aug 15, 2025, 04:31 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 19, 2025 | Sale | $8.27 | 1,945 | 16,085 | 31,565 | Mar 20, 2025, 06:05 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 18, 2025 | Sale | $8.67 | 2,266 | 19,646 | 33,510 | Mar 20, 2025, 06:05 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 15, 2025 | Option/RSU Exercise | - | 13,475 | - | 35,776 | Mar 18, 2025, 04:11 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Dec 09, 2024 | Sale | $13.61 | 13,666 | 185,978 | 23,028 | Dec 11, 2024, 04:05 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Dec 06, 2024 | Sale | $12.78 | 9,696 | 123,891 | 35,142 | Dec 10, 2024, 07:01 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Dec 03, 2024 | Option/RSU Exercise | - | 6,000 | - | 44,838 | Dec 05, 2024, 04:21 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Dec 01, 2024 | Option/RSU Exercise | - | 33,927 | - | 38,838 | Dec 03, 2024, 04:14 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | May 20, 2024 | Option/RSU Exercise | $7.07 | 8,599 | 60,795 | 11,197 | May 22, 2024, 04:15 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | May 20, 2024 | Sale | $15.04 | 8,599 | 129,327 | 2,598 | May 22, 2024, 04:15 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 28, 2024 | Sale | $13.20 | 5,126 | 67,668 | 2,698 | Apr 01, 2024, 04:14 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 15, 2024 | Option/RSU Exercise | - | 7,475 | - | 10,073 | Mar 19, 2024, 08:29 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 19, 2024 | Sale | $6.10 | 2,349 | 14,326 | 7,724 | Mar 19, 2024, 08:29 PM | |
| STOK | Stoke Therapeutics, Inc. | Jonathan Allan | General Counsel & Corp Sec | Jun 21, 2023 | Sale | $13.48 | 1,948 | 26,252 | 0 | Jun 23, 2023, 04:45 PM |